US Stock MarketDetailed Quotes

Immatics (IMTX)

Watchlist
  • 10.790
  • -0.200-1.82%
Close May 1 16:00 ET
  • 10.790
  • 0.0000.00%
Post 17:13 ET
1.45BMarket Cap-5.71P/E (TTM)

Immatics (IMTX) Revenue Breakdown Overview

By Business/Source

Currency:EUR
2025/FY
Stock NameRevenueRatio
Research and development of PRAME-directed immunotherapies that harness the power of T cells for48.27M100.00%

By Country/Region

Currency:EUR
2025/FY
Stock NameRevenueRatio
Moderna, United States37.25M77.17%
Bristol-Myers-Squibb (BMS) United States11.02M22.83%
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More